| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/17/2001 | CN1279946A Berberine hydrochloride suppository and its producing method |
| 01/17/2001 | CN1279945A Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 01/17/2001 | CN1279944A Effervescent tablets for curing vaginitis and its preparing method |
| 01/17/2001 | CN1279943A Concentrated granule medicine of famous decoction formulation and its preparation |
| 01/17/2001 | CN1279942A Medicinal aerosol for curing respiratory system disease |
| 01/17/2001 | CN1279941A Medical plaster |
| 01/17/2001 | CN1060770C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 01/17/2001 | CN1060672C Congelation treating suspension |
| 01/17/2001 | CN1060664C Chinese drug for curing and preventing mastosis and its preparing method |
| 01/17/2001 | CN1060663C Compound Tibet capillary artemisia patent medicine |
| 01/17/2001 | CN1060660C Chinese herb medicine powder for rhinitis |
| 01/17/2001 | CN1060659C Pill medicine for cancer and proparation method |
| 01/17/2001 | CN1060658C Pure Chinese herbal medicine film liquid for burn and its producing process |
| 01/17/2001 | CN1060657C Nouring medicine for preventing and curing toxic and side effect after tumor radiotherapy |
| 01/17/2001 | CN1060656C Yuganwan pill-medicine for hepatitis |
| 01/17/2001 | CN1060651C Preparing technology for instant granules of single chinese medicine herb tablet |
| 01/17/2001 | CN1060645C Wild conttonrose hibiscus extract |
| 01/16/2001 | US6175054 A multilayered wound dressing film comprising the sodium salt of hyaluronic acid and an active substance to be released into a wound |
| 01/16/2001 | US6174904 Treating glycometabolism disorders in mammals by administering therapeutically effective amount of an insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor |
| 01/16/2001 | US6174902 Treating ulcers by administering to human therapeutically effective amount of optically pure r(+)isomer of rabeprazole, or a pharmaceutically acceptable salt |
| 01/16/2001 | US6174890 A synergistic biological, neurometabolic and celltrophic composition comprising antioxidative and -catabolic stress (methionine),-anabolic drugs, vasodilative and normo-lipidemic drugs (nicotinic acid), energoactive and antitoxic |
| 01/16/2001 | US6174882 Treating psychosis, acute mania, schizophrenia, excessive agression, substance abuse and fungal dermatitis; bipolar, autistism, tic, functional bowel and attention deficit hyperactivity disorders, anxiolytic agents; antidepressants |
| 01/16/2001 | US6174876 Use of boswellic acid for treating brain tumors |
| 01/16/2001 | US6174873 Oral administration of adenosine analogs |
| 01/16/2001 | US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes |
| 01/16/2001 | US6174871 Gene therapies for enhancing cardiac function |
| 01/16/2001 | US6174866 Edible anti-parasite medication for domesticated animals |
| 01/16/2001 | US6174864 Methods for the prevention or treatment of inflammatory bowel diseases |
| 01/16/2001 | US6174548 Pharmaceutical composition of omeprazole for oral administration which consists essentially of a tabletted core and coating layer |
| 01/16/2001 | US6174547 Comprising a drug formulation that self-emulsifies to enhance the solubility, the dissolution, and the bioavailability of the drug |
| 01/16/2001 | US6174546 Transdermal pressure sensitive adhesive drug delivery system |
| 01/16/2001 | US6174545 Device for the transdermal administration of testosterone through intact, non-scrotal skin over an administration period |
| 01/16/2001 | US6174543 Antidiabetic external skin application composition |
| 01/16/2001 | US6174540 Comprising therepeutic agent selected from insecticides, acaricides, parasiticides, growth enhancers, and nasids; hydrogenated castor oil; hydrophobic carrier |
| 01/16/2001 | US6174529 Oral therapy for the treatment of allergies and method of manufacture |
| 01/16/2001 | US6174524 Gelling ophthalmic compositions containing xanthan gum |
| 01/16/2001 | US6174518 Photoprotective/cosmetic compositions comprising w/o/w stable triple emulsions |
| 01/16/2001 | US6174300 Fluid delivery device with temperature controlled energy source |
| 01/16/2001 | CA2052615C Pharmaceutical composition in gel form in a dispensing package |
| 01/14/2001 | CA2277407A1 Pharmaceutical tablet comprising an nsaid and misoprostol |
| 01/11/2001 | WO2001002479A1 Pre-formed, self-adhesive sheet devices suitable for topical application |
| 01/11/2001 | WO2001002478A1 Pre-formed, self-adhesive sheet devices suitable for topical application |
| 01/11/2001 | WO2001002460A1 Biodegradable block copolymers with modifiable surface |
| 01/11/2001 | WO2001002426A1 A substantially crystalline form of melagatran |
| 01/11/2001 | WO2001002410A1 Novel process |
| 01/11/2001 | WO2001002360A1 Process for preparing amlodipine benzenesulphonate |
| 01/11/2001 | WO2001002267A1 Packaging bag for plaster and packaged plaster |
| 01/11/2001 | WO2001002087A1 Method for producing aqueous colloidal dispersions of nanoparticles |
| 01/11/2001 | WO2001002036A1 Container with constituents of the acid concentrate for a dialysis fluid and a device for preparing the latter |
| 01/11/2001 | WO2001002024A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | WO2001002016A1 Nasogastric enteral formulations |
| 01/11/2001 | WO2001002004A1 Peritoneal dialysis solution containing antioxidant for treating renal failure |
| 01/11/2001 | WO2001002002A1 Stabilized pharmaceutical composition in lyophilized form |
| 01/11/2001 | WO2001001998A2 Treatment of endometriosis with antileukoprotease |
| 01/11/2001 | WO2001001994A1 Water resistant film-forming antimicrobial skin-preparation |
| 01/11/2001 | WO2001001992A1 A solid formulation of glucosamine sulphate |
| 01/11/2001 | WO2001001991A1 Pharmaceutical tablets |
| 01/11/2001 | WO2001001990A1 Adhesive preparation for percutaneous absorption |
| 01/11/2001 | WO2001001984A1 Levodopa / carbidopa / entacapone pharmaceutical preparation |
| 01/11/2001 | WO2001001982A1 Aminoethanesulfonic acid-containing preparations |
| 01/11/2001 | WO2001001967A1 Microreservoir system on the basis of polysiloxanes and ambiphilic solvents |
| 01/11/2001 | WO2001001966A2 Sustained release dosage form unit having latex coating and method of making the same |
| 01/11/2001 | WO2001001965A1 Grf-containing lyophilized pharmaceutical compositions |
| 01/11/2001 | WO2001001964A2 Ionically formulated biomolecule microcarriers |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001961A1 Oral micro-emulsion composition of silybin |
| 01/11/2001 | WO2001001960A1 Clear oil-containing pharmaceutical compositions |
| 01/11/2001 | WO2001001959A1 Ophthalmic compositions in form of aqueous gels |
| 01/11/2001 | WO2001001958A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 01/11/2001 | WO2001001957A1 Local drug delivery |
| 01/11/2001 | WO2001001956A2 Solid preparations containing paroxetine |
| 01/11/2001 | WO2001001955A1 Nasal formulation of an antifungal |
| 01/11/2001 | WO2001001950A1 Pre-formed gel sheet |
| 01/11/2001 | WO2001001942A1 Systems comprising organosiloxane resins for delivering oral care substances and for prolonging such delivery |
| 01/11/2001 | WO2001001941A1 Compositions comprising organosiloxane resins for delivering xylitol to the oral cavity |
| 01/11/2001 | WO2001001939A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001929A2 Microcapsules iv |
| 01/11/2001 | WO2001001928A1 Microcapsules - iii |
| 01/11/2001 | WO2001001927A1 Microcapsules - i |
| 01/11/2001 | WO2001001926A1 Microcapsules - ii |
| 01/11/2001 | WO2001001923A2 Composition based on fluorinated polymer and alpha-hydroxy-acid salt for topical use for skin protection |
| 01/11/2001 | WO2001001899A1 Methods and materials for preterm birth prevention |
| 01/11/2001 | WO2001001890A1 Stent coating |
| 01/11/2001 | WO2001001797A1 Oral form of administration |
| 01/11/2001 | WO2001001749A2 FVIIa ANTAGONISTS |
| 01/11/2001 | WO2000064417A3 Inactivated microorganisms comprising substances having pharmacological activity |
| 01/11/2001 | WO2000062801A3 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/11/2001 | WO2000061543A3 Esters of l-carnitine or alkanoyl l-carnitines |
| 01/11/2001 | WO2000061189A3 Water-soluble compositions of bioactive lipophilic compounds |
| 01/11/2001 | WO2000061068A3 Anthelmintic compositions |
| 01/11/2001 | WO2000057851A3 High potency dihydroergotamine compositions |
| 01/11/2001 | WO2000051603A3 Compositions of remifentanil |
| 01/11/2001 | WO2000041538A3 Dermal compositions |
| 01/11/2001 | DE19958554A1 Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln Microreservoir system based on polysiloxanes, and the ambiphilic solvent |
| 01/11/2001 | DE19931667A1 Flexible, water-soluble or water-dispersible coating agent, binder or film former for pharmaceutical formulations, comprises new or known vinyl ester-polyether graft copolymer, |
| 01/11/2001 | DE19931399A1 Kapsel für die kontrollierte Freisetzung von Aktivstoffen Capsule for controlled release of active substances |
| 01/11/2001 | DE19930795A1 Encapsulation of active agents, especially drugs, by diffusion into previously prepared particles, e.g. based on alginate, to give injectable slow release formulations |
| 01/11/2001 | DE19930729A1 Blockcopolymere zur Herstellung biomimetischer Oberflächen Block copolymers for the preparation of biomimetic surfaces |
| 01/11/2001 | DE19930030A1 Orale Darreichungsform The oral dosage form |